FDA Inspection 1017529 — Eric C. Hu, M.D., Principle Investigator
The FDA completed an inspection of Eric C. Hu, M.D., Principle Investigator on June 16, 2017 in Pasadena, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 16, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Pasadena, CA (United States)
Additional Details
Clinical Investigator (CI)